Prot #VB-111-215: A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined with Bevacizumab vs. Bevacizumab Monotherapy in Patients with Recurrent Glioblastoma

Project: Research project

Project Details

StatusFinished
Effective start/end date5/18/165/18/19

Funding

  • PPD Investigator Services, LLC (Prot #VB-111-215)
  • Vascular Biogenics Ltd. (Prot #VB-111-215)